EVOKE PHARMA, INC. Notes Payable, Noncurrent
EVOKE PHARMA, INC. had Notes Payable, Noncurrent of $5.00 million as of 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermNotesPayable · last filed 2024-05-14
- 2023-12-31: Notes Payable, Noncurrent $5.00M.
- 2023-09-30: Notes Payable, Noncurrent $5.00M.
- 2023-06-30: Notes Payable, Noncurrent $5.00M.
- 2023-03-31: Notes Payable, Noncurrent $5.00M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2023-12-31 | $5.00M 10-K · filed 2024-03-14 |
| 2023-09-30 | $5.00M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $5.00M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $5.00M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $5.00M 10-K/A · filed 2024-05-14 |
| 2022-09-30 | $5.00M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $5.00M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $5.00M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $5.00M 10-K · filed 2023-03-21 |
| 2021-09-30 | $5.00M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $5.00M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $5.00M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $5.00M 10-K · filed 2022-03-08 |
| 2020-09-30 | $2.00M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $2.00M 10-Q · filed 2020-08-06 |